nifedipine has been researched along with succinylcholine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Fletcher, JE; Huggins, FJ; Rosenberg, H | 1 |
| Chang, CC; Chiou, LC; Hong, SJ; Huang, CY; Hwang, LL | 1 |
| Batra, YK; Indu, B; Puri, GD; Singh, H | 1 |
| Adam, LP; Henderson, EG | 1 |
| Fischer, M; Schäfer, SS | 1 |
1 review(s) available for nifedipine and succinylcholine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for nifedipine and succinylcholine
| Article | Year |
|---|---|
Nifedipine attenuates the intraocular pressure response to intubation following succinylcholine.
Topics: Adult; Anesthesia, Intravenous; Blood Pressure; Female; Humans; Intraocular Pressure; Intubation, Intratracheal; Male; Nifedipine; Placebos; Random Allocation; Succinylcholine; Systole; Thiopental | 1989 |
5 other study(ies) available for nifedipine and succinylcholine
| Article | Year |
|---|---|
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
The importance of calcium ions for in vitro malignant hyperthermia testing.
Topics: Caffeine; Calcium; Contracture; Drug Interactions; Halothane; Humans; In Vitro Techniques; Malignant Hyperthermia; Muscle Contraction; Muscles; Nifedipine; Quinacrine; Strontium; Succinylcholine; Verapamil | 1990 |
Nicardipine inhibits axon conduction but causes dual changes of acetylcholine release in the mouse motor nerve.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Acetylcholine; Action Potentials; Animals; Axonal Transport; Axons; Chick Embryo; Diaphragm; Diltiazem; Female; In Vitro Techniques; Male; Mice; Mice, Inbred ICR; Motor Neurons; Muscle Contraction; Nicardipine; Nifedipine; Sodium Channels; Succinylcholine; Verapamil | 1989 |
Augmentation of succinylcholine-induced neuromuscular blockade by calcium channel antagonists.
Topics: Animals; Bepridil; Calcium Channel Blockers; Drug Synergism; In Vitro Techniques; Neuromuscular Junction; Nicardipine; Nifedipine; Pyrrolidines; Rana pipiens; Receptors, Nicotinic; Succinylcholine; Synaptic Transmission; Verapamil | 1986 |
Effects of the calcium antagonist nifedipine on the afferent impulse activity of isolated cat muscle spindles.
Topics: Action Potentials; Animals; Calcium Channel Blockers; Cats; In Vitro Techniques; Muscle Contraction; Muscle Spindles; Nerve Endings; Neural Conduction; Neuromuscular Junction; Neurons, Afferent; Nifedipine; Succinylcholine; Synaptic Transmission | 2002 |